Clinical Trials on Right Heart Dysfunction in Japan

Total 1355 results

C. R. Bard
Medicon, Inc.

Completed

A Safety and Effectiveness Study of the MD-12-001 Stent in the Treatment of Superficial Femoral Artery or Popliteal Artery Blockages in Japanese Patients (Reliable)

Arterial Occlusive Disease

Japan
GlaxoSmithKline

Completed

The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

Thrombosis, Venous

Japan
Novartis Pharmaceuticals

Completed

Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients

Acute Heart Failure

Japan
Boston Scientific Corporation

Completed

Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)

Peripheral Arterial Disease

Japan
Pfizer
Bristol-Myers Squibb

Terminated

A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients

Acute Coronary Syndrome

Japan
AstraZeneca

Active, not recruiting

Forxiga HF General Drug Use-Results Study

Heart Failure

Japan
Novartis Pharmaceuticals

Terminated

An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.

Heart Failure With Preserved Ejection Fraction (HFpEF)

Japan
Astellas Pharma Inc

Completed

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery

Venous Thromboembolism

Japan, Korea, Republic of, Taiwan, Thailand
Celgene

Completed

Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refractory or Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

Japan
Celgene

Completed

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Multiple Myeloma

United States, Japan
Bausch & Lomb Incorporated

Completed

A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.

Primary Open Angle Glaucoma | Ocular Hypertension

Japan
Boston Scientific Corporation
ICON Clinical Research

Completed

Heart Failure and Sudden Cardiac Death Japan Registry (HINODE)

Heart Failure | Arrhythmias, Cardiac | Sudden Cardiac Death

Japan
BioCryst Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in Japan (APeX-J)

Hereditary Angioedema, HAE

Japan
Tokai University
Abbott Medical Devices; Kaneka Medical America LLC; Terumo Medical Corporation; Asahi Intech and other collaborators

Completed

Guidewire for Chronic Total Occlusion (G-FORCE)

Coronary Occlusion

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient

Hypertension

Japan
Nippon Medical School
Daiichi Sankyo Co., Ltd.

Active, not recruiting

STroke Secondary Prevention With Catheter ABLation and EDoxaban for Patients With Non-valvular Atrial Fibrillation: STABLED Study (STABLED)

Ischemic Stroke | Atrial Fibrillation Non-Rheumatic

Japan
Canadian Institutes of Health Research (CIHR)
Vanderbilt University

Completed

Syncope: Pacing or Recording in the Later Years (Spritely)

Heart Block | Syncope | Conduction Disorder of the Heart

United Kingdom, Canada, United States, Malaysia, Japan
VZW Cardiovascular Research Center Aalst

Recruiting

Pullback Pressure Gradient (PPG) Global Registry (PPG Global)

Non ST Elevation Myocardial Infarction | Chronic Coronary Insufficiency

United Kingdom, United States, Australia, Belgium, Italy, Japan
Cook Group Incorporated

Completed

Zenith® TXD Post-market Surveillance in Japan

Aortic Dissection

Japan
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque (PREVENT)

Coronary Artery Disease | Plaque, Atherosclerotic

Korea, Republic of, Taiwan, United States, Japan, New Zealand
Seoul National University Hospital
The First Affiliated Hospital with Nanjing Medical University; National Taiwan... and other collaborators

Unknown

Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)

Multivessel Coronary Artery Disease

Korea, Republic of, China, Japan, Singapore, Taiwan
Novartis Pharmaceuticals

Completed

Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

Essential Hypertension

Japan
Novartis Pharmaceuticals

Completed

Dose Escalation Study of LGH447 in Japanese Patients With Relapsed and/or Refractory Hematologic Malignancies

Multiple Myeloma

Japan
Chiu Yee Liona Poon

Completed

Prediction of Preeclampsia (PE) at 11-13 Week

Pre-Eclampsia

Thailand, Singapore, Hong Kong, Japan, China, India, Taiwan
Micell Technologies
Cardialysis BV; ClinLogix. LLC

Unknown

Trial of MiStent Compared to Xience in Japan (DESSOLVEJ)

Coronary (Artery); Disease

Japan
Kansai Rosai Hospital
Association for Establishment of Ebvidence in Interventions

Unknown

Sufficient Treatment of Peripheral Intervention by Cilostazol (STOP-IC)

Arteriosclerosis Obliterans

Japan
Pfizer
Bristol-Myers Squibb

Completed

A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

Atrial Fibrillation

Japan
Biogen

Completed

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) (TALLY)

Cognitive Impairment Associated With Schizophrenia

Spain, United States, Germany, Japan, United Kingdom
Juntendo University
Boehringer Ingelheim

Recruiting

Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure (EMPA-AHF)

Acute Heart Failure

Japan
Ottawa Heart Institute Research Corporation
Far Eastern Memorial Hospital; London Health Sciences Centre; Medtronic; The Methodist... and other collaborators

Recruiting

The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial (MIST)

Coronary Artery Disease

United States, Belgium, Canada, China, Germany, India, Japan, Singapore, Taiwan
Kyoto Prefectural University of Medicine

Unknown

Pitavastatin on Carotid Intima-media Thickness (PEACE)

Carotid Artery Diseases | Hyperlipidemia

Japan
Terumo Europe N.V.
Cromsource

Completed

DIStal Versus COnventional RADIAL Access for Coronary Angiography and Intervention

Coronary Disease

Italy, Belgium, United Kingdom, Hungary, Japan, Czechia, Germany, Netherlands, North Macedonia, Switzerland
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Cushing's Syndrome | Ectopic Corticotropin Syndrome | Adrenal Adenoma | Adrenal Carcinoma | AIMAH | PPNAD

Japan
Philip Moons

Completed

Patient-Reported Outcomes in Adults With Congenital Heart Disease (APPROACH-IS)

Heart Defects, Congenital

Norway, Taiwan, Belgium, Netherlands, United States, Sweden, Switzerland, Canada, Argentina, Australia, France, India, Italy, Japan, Malta
Ministry of Health, Labour and Welfare, Japan

Unknown

SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF) (SAMURAI-NVAF)

Atrial Fibrillation | Stroke, Acute

Japan
GlaxoSmithKline

Completed

The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

Embolism, Pulmonary

Japan
Celgene Corporation

Completed

Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

Japan
BeiGene

Active, not recruiting

Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies

Mature B-cell Malignancies

Japan
Novartis Pharmaceuticals

Completed

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes

Periodic Fevers Syndrome

Japan
Eli Lilly and Company

Terminated

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Alzheimer's Disease

United States, Italy, Japan, Spain, Netherlands
AstraZeneca

Active, not recruiting

Brilinta Clinical Experience Investigation (BRLCEIACS/OMI)

Acute Coronary Syndrome, Old Myocardial Infarction

Japan
Janssen Pharmaceutical K.K.

Completed

A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM)

Waldenstrom Macroglobulinemia

Japan
Astellas Pharma Inc

Completed

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Atrial Fibrillation

Taiwan, Japan, Korea, Republic of, New Zealand, Singapore, South Africa, Thailand, Australia, Hong Kong, Malaysia
The Hospital for Sick Children

Recruiting

Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block

Heart Block Complete | Heart Block Second Degree

United States, France, Canada, Netherlands, Japan, Taiwan, Germany, Finland, Sweden, Bulgaria, Hong Kong, Poland
Medtronic Bakken Research Center
Medtronic; Medtronic Japan Co., Ltd.

Completed

Mid-Q Response Study

Heart Failure | Left Bundle-Branch Block | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV | Heart Failure With Reduced Ejection Fraction (HFrEF)

Korea, Republic of, Japan, Singapore, Taiwan, Hong Kong, Indonesia, Malaysia, China, Philippines, Brunei Darussalam
Bristol-Myers Squibb

Active, not recruiting

A Rollover Study of CC-122

Non-Hodgkin Lymphoma

Netherlands, France, United States, Japan
Takeda

Completed

A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

Hypertension

Japan
Kyowa Kirin Co., Ltd.

Completed

Open Label Extension Study of AMG 531 in Japanese Subjects With ITP

Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

Pulmonary Hypertension

Japan
Boehringer Ingelheim

Completed

A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin

Atrial Fibrillation

Japan

Clinical Trials on Right Heart Dysfunction in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations